Cases 11 - 20 of 105
KPH Healthcare Services, Inc. v. AstraZeneca Pharmaecuticals LP et al
as 1:2020cv01201
Plaintiff:
KPH Healthcare Services, Inc. and Kinney Drugs, Inc.
Defendant:
AstraZeneca Pharmaecuticals LP, Astrazeneca LP, Astrazeneca UK Limited and others
Cause Of Action: 15 U.S.C. § 15
Walgreen Co. et al v. Astrazeneca Pharmaceuticals L.P. et al
as 1:2020cv01087
Plaintiff:
H-E-B, L.P., The Kroger Co., Walgreen Co. and others
Defendant:
AstraZeneca L.P., AstraZeneca Pharmaceuticals L.P., AstraZeneca UK Limited and others
Cause Of Action: 15 U.S.C. § 2
Hy-Vee, Inc. v. Astrazeneca Pharmaceuticals LP et al
as 1:2020cv01089
Defendant:
Par Pharmaceutical Inc., Astrazeneca LP, Astrazeneca UK Limited and others
Plaintiff:
Hy-Vee, Inc.
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
CVS Pharmacy, Inc. et al v. Astrazeneca Pharmaceuticals L.P., et al
as 1:2020cv01086
Defendant:
AstraZeneca L.P., AstraZeneca Pharmaceuticals L.P., AstraZeneca UK Limited and others
Plaintiff:
Rite Aid Hdqtrs Corp., CVS Pharmacy, Inc. and Rite Aid Corporation
Cause Of Action: 15 U.S.C. § 1
In re: Seroquel XR (Extended Release Quetiapine Fumarate) Litigation All End-Payor Class Actions
as 1:2020cv01090
Defendant:
Par Pharmaceutical Inc., Handa Pharmaceuticals LLC, Accord Pharmaceuticals, Inc. and others
Plaintiff:
Uniformed Firefighters' Association of Greater New York Security Benefit Fund, Pipe Trades Services MN Welfare Fund, Mayor and City Council of Baltimore, Maryland and others
Cause Of Action: 15 U.S.C. § 2 Antitrust Litigation
In re: Seroquel XR (Extended Release Quetiapine Fumarate) Antitrust Litigation
as 1:2020cv01076
Defendant:
Par Pharmaceutical Inc., AstraZeneca UK Limited, Handa Pharmaceuticals LLC and others
Plaintiff:
JM Smith Corporation on behalf of itself and all others similarly situated doing business as Smith Drug Company, Rite Aid Hdqtrs Corp., Walgreen Co. and others
Consolidated Plaintiff:
Hy-Vee, Inc.
Cause Of Action: 15 U.S.C. § 15 Antitrust Litigation
Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc.
as 1:2019cv02216
Defendant:
Mylan Pharmaceuticals Inc.
Plaintiff:
Takeda Pharmaceuticals U.S.A., Inc.
3Rd Party Defendant:
Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.
Intervenor:
Par Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Par Pharmaceutical, Inc. et al v. Fresenius Kabi USA, LLC
as 1:2019cv01985
Plaintiff:
Par Sterile Products, LLC, Par Pharmaceutical, Inc. and Endo Par Innovation Company, LLC
Defendant:
Fresenius Kabi USA, LLC
Cause Of Action: 35 U.S.C. § 271
Par Pharmaceutical, Inc. et al v. American Regent, Inc.
as 1:2019cv01490
Defendant:
American Regent, Inc.
Plaintiff:
Par Sterile Products, LLC, Par Pharmaceutical, Inc. and Endo Par Innovation Company, LLC
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
